Celltrion Group provides biosimilar and innovative biopharmaceutical medications to help increase patient access to advanced therapies around the world.
Celltrion Group offers biologics to about 110 countries, along with more than 30 global partners around the world. With hands-on experience and knowledge accumulated through years of working in the advanced pharmaceutical markets around the world, Celltrion Group has been securing distribution channels and providing patients with biosimilars at affordable prices.
The main focus of this role will be the promotion and sales of the CTHC Biosimilar and Biologic product range and supporting services.

Celltrion is a fully integrated biopharmaceutical company dedicated to delivering innovative and affordable medications to improve patients’ access to advanced therapies. Pioneering monoclonal antibody (mAb) biosimilars, built on a legacy of trust, we are advancing antibody-based biologics to address unmet medical needs. Our end-to-end capabilities - from R&D to distribution - ensure efficiency, quality, and innovation at every stage, bringing life-changing therapies to patients worldwide. Partnering with purpose, we are committed to driving customer intimacy to co-creating value at every touchpoint across the care journey. #BuiltonTrustTowardInnovation
For guidelines: https://bit.ly/4jv2wf2